BPC Latest Updates
Brookside Energy (ASX:BRK)
Brookside Energy
Deep Dive
JUN 2026
In this BPC Corporate Showcase Deep Dive, Brookside Energy Managing Director David Prentice joins Andrew Murphy to discuss the company’s transition from exploration to production…
LTR Pharma (ASX:LTP):
A license to Disrupt
LTR Pharma (ASX: LTP) is a commercial stage pharmaceutical company focused on repurposing established therapeutics to address unmet medical needs.
BPC Corporate Showcase: Black Canyon Limited (ASX:BCA)
Managing Director Brendan Cummins joins Scarlet Alexander in our latest Corporate Showcase to explore Wandanya’s scale, development potential, infrastructure advantages, and the milestones ahead.
All Your Investments On One Platform
Consolidate all your investments into one easy-to-use platform. With 24/7 access from any device, you can monitor your portfolio in real-time.
Book a complimentary portfolio review today and experience the BPC Wealth Management Investor Portal—your gateway to smarter investing.
Subscribe to
Client Chairman's Lists
Join the Chairman’s List for timely company updates, strategic insights and direct access to key developments as they unfold. Designed for investors who value informed, considered access.
- AML Metals Chairman's List
- Indigo Metals Chairman's List
- Brookside Energy Chairman's List
- Terrain Minerals Chairman's List
BPC Wealth Management
Portfolio Review
As part of our Wealth Management offering, we invite you to access a complimentary portfolio review with our experienced advisory team. This review is designed to provide a considered assessment of your current portfolio positioning, risk exposure and broader investment strategy, helping you identify whether your investments remain aligned with your objectives in the current market environment.
Luke brings ~15 years of experience across equity markets, including a background as an equity analyst and portfolio manager, with a focus on investment strategy, portfolio construction and small to micro-cap opportunities.
A clearer portfolio starts with a timely review
BPC Sector Spotlight Series
Sector Spotlight Series
BPC’s Sector Spotlight Series explores a different market sector each month, bringing together industry experts to share their perspectives on the trends, challenges and opportunities shaping it.
Each session is designed to give investors direct access to informed sector commentary and a clearer understanding of the forces influencing the market.
Inside perspectives on the sectors moving into focus.
Athlete's Journey
Introducing “Athlete’s Journey – Winning On & Off The Field” a special podcast series looking at the financial journey of athletes through the eyes of some of Australia’s most influential sporting figures.
BPC at RIU 2026
BPC at RIU
BPC engages with a range of companies across the resources sector at the RIU Conference, recording interviews and capturing what’s driving the market. We’ll be sharing key takeaways, the themes we’re hearing on the ground, and highlights from our RIU conversations. Want a deeper dive on the companies we’ve interviewed?
As Barclay Sees It with BPC
What Have We Learnt this Reporting Season?
This week on As Barclay Sees It, Ryan Morton looks at what FY26 reporting season has revealed about the Australian market. More than 250 ASX-listed companies have reported over the past five weeks, giving investors a clearer read on profits, dividends, margins and operating conditions heading into the remainder of 2026.
Markets & Matchups with BPC
Season II - Episode 26
We’re back with another episode of Markets & Match-Ups, covering the first week of the new financial year, key market catalysts, and another big week across sport.
Follow Markets & Match-Ups throughout the season, and connect with the BPC team to stay across the market moves that matter for your investment strategy.
BPC Research & Insights
BPC Research
Explore in-depth research and insights from BPC’s Research Department. Our reports focus on specific industries and companies, providing valuable analysis for investors of all levels. Each report highlights key trends, opportunities and profiles of companies within the sector, offering a comprehensive view to help guide investment decisions.
LTR Pharma: Partnerships Secure. US Commercialisation Begins
RESEARCH UPDATE
LTR Pharma: Partnerships Secure. US Commercialisation Begins
LTR Pharma (ASX: LTP) is a commercial stage pharmaceutical company focused on repurposing established therapeutics to address unmet medical needs. By leveraging proven active ingredients alongside differentiated delivery technologies, the company aims to develop therapies that offer faster onset, improved patient experience, and enhanced clinical utility.
Research built for clarity
Client Transactions
BPC Community
"Barclay Pearce Capital is whole-heartedly committed to enriching the lives and wellbeing of our community to make a lasting difference in people's lives."
-Donna Warner, Director, Business Administration, Barclay Pearce Capital